Time for consolidation in Germany
Commercial biotechnology in Germany has taken off during the past decade, but creating a viable sector may require a change in strategy in the future.
Gespeichert in:
Veröffentlicht in: | Nature biotechnology 2002-05, Vol.20 (5), p.441-444 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Commercial biotechnology in Germany has taken off during the past decade, but creating a viable sector may require a change in strategy in the future. |
---|---|
ISSN: | 1087-0156 1546-1696 |
DOI: | 10.1038/nbt0502-441 |